Liquid Biopsy for HER2 Status Assessment in Breast Cancer Using Surrogate DNA Methylation Markers

被引：0
|
作者：
Zhang, Xianyu
Lu, Shiyao
Li, Hui
Liu, Xin
Wang, Jun
Zeng, Liuhong
Lu, Zhipeng
Liu, Siyu
Yin, Yanling
Bibikova, Marina
Chen, Zhiwei
Fan, Jian-Bing
Pang, Da
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P1-05-27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-05-27
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Liquid biopsy determination of HER2 status in breast cancer: results from a novel epigenomic platform
    Parsons, Heather
    Baca, Sylvan
    D'Ippolito, Anthony
    Jeong, Hyun-Hwan
    Smith, Kalie
    Tarantino, Paolo
    Hughes, Melissa
    Sendrick, Kerry
    Painter, Corrie
    Seo, Ji-Heui
    Grant, Elizabeth
    Guess, Jamey
    Davidsohn, Matthew
    Lakshminarayanan, Gitanjali
    Strauss, Sarah
    Savignano, Hunter
    Canniff, John
    Fortunato, Brad
    Eaton, Matthew
    Choueiri, Toni
    Tolaney, Sara
    Freedman, Matthew
    Lin, Nancy
    CANCER RESEARCH, 2024, 84 (09)
  • [12] Assessment of HER2/neu status in core needle biopsy of 215 patients with primary breast cancer
    Taucher, S
    Rudas, M
    Gnant, M
    Kandioler, D
    Pichler, B
    Roka, S
    Mittlböck, M
    Steger, G
    Jakesz, R
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S111 - S111
  • [13] Assessment of hormone receptor status and HER2 expression by fine needle aspiration biopsy in breast cancer
    Hussain, M
    Cangiarella, J
    Volm, M
    Harris, MN
    Roses, DF
    Berman, RS
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S54 - S55
  • [14] Prognostic markers in breast cancer:: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer
    Taucher, S
    Rudas, M
    Mader, RM
    Gnant, M
    Dubsky, P
    Roka, S
    Bachleitner, T
    Kandioler, D
    Steger, G
    Mittlböck, M
    Jakesz, R
    WIENER KLINISCHE WOCHENSCHRIFT, 2004, 116 (1-2) : 26 - 31
  • [15] HER2 assessment in breast cancer
    Sapino, Anna
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S30 - S31
  • [16] The assessment of HER2 status in breast cancer: the past, the present, and the future
    Nitta, Hiroaki
    Kelly, Brian D.
    Allred, Craig
    Jewell, Suzan
    Banks, Peter
    Dennis, Eslie
    Grogan, Thomas M.
    PATHOLOGY INTERNATIONAL, 2016, 66 (06) : 313 - 324
  • [17] Assessment of HER2 status in breast cancer by fluorescence in situ hybridisation
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 235 - 236
  • [18] Assessment of HER2 status in breast cancer: why, when and how?
    Dowsett, M
    Cooke, T
    Ellis, I
    Gullick, WJ
    Gusterson, B
    Mallon, E
    Walker, R
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (02) : 170 - 176
  • [19] HER2 status in bilateral breast cancer
    Crowe, Joseph P.
    Patrick, Rebecca J.
    Rybicki, Lisa A.
    Budd, G. Thomas
    Escobar, Pedro F.
    Tubbs, Raymond R.
    Hicks, David G.
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 2006, 51 (05) : 219 - 223
  • [20] HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma
    Purdie, Colin A.
    Jordan, Lee B.
    McCullough, Jean B.
    Edwards, Sharon L.
    Cunningham, Joan
    Walsh, Miriam
    Grant, Andrew
    Pratt, Norman
    Thompson, Alastair M.
    HISTOPATHOLOGY, 2010, 56 (06) : 702 - 707
12345